![]() |
Name |
Cytochalasin J3
|
Molecular Formula | C28H35NO3 | |
IUPAC Name* |
(1S,3S,4R,5S,8R,9R,11R,14S,16R,17S,18R)-5-benzyl-9-hydroxy-3,12,14-trimethyl-2-methylidene-19-oxa-6-azapentacyclo[14.2.1.04,8.08,18.011,17]nonadec-12-en-7-one
|
|
SMILES |
C[C@H]1C[C@@H]2[C@H]3[C@@H](C[C@H]([C@]45[C@@H]3[C@H](O2)C(=C)[C@H]([C@H]4[C@@H](NC5=O)CC6=CC=CC=C6)C)O)C(=C1)C
|
|
InChI |
InChI=1S/C28H35NO3/c1-14-10-15(2)19-13-22(30)28-24(20(29-27(28)31)12-18-8-6-5-7-9-18)16(3)17(4)26-25(28)23(19)21(11-14)32-26/h5-10,14,16,19-26,30H,4,11-13H2,1-3H3,(H,29,31)/t14-,16-,19+,20+,21-,22-,23-,24+,25+,26-,28-/m1/s1
|
|
InChIKey |
WSPVFJOMQYINNH-BNBLUJNUSA-N
|
|
Synonyms |
Cytochalasin J3
|
|
CAS | NA | |
PubChem CID | 139591402 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 433.6 | ALogp: | 3.3 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 58.6 | Aromatic Rings: | 6 |
Heavy Atoms: | 32 | QED Weighted: | 0.673 |
Caco-2 Permeability: | -5.094 | MDCK Permeability: | 0.00003500 |
Pgp-inhibitor: | 0.208 | Pgp-substrate: | 0.994 |
Human Intestinal Absorption (HIA): | 0.016 | 20% Bioavailability (F20%): | 0.025 |
30% Bioavailability (F30%): | 0.62 |
Blood-Brain-Barrier Penetration (BBB): | 0.253 | Plasma Protein Binding (PPB): | 87.65% |
Volume Distribution (VD): | 1.788 | Fu: | 6.33% |
CYP1A2-inhibitor: | 0.22 | CYP1A2-substrate: | 0.135 |
CYP2C19-inhibitor: | 0.838 | CYP2C19-substrate: | 0.706 |
CYP2C9-inhibitor: | 0.832 | CYP2C9-substrate: | 0.052 |
CYP2D6-inhibitor: | 0.044 | CYP2D6-substrate: | 0.291 |
CYP3A4-inhibitor: | 0.936 | CYP3A4-substrate: | 0.473 |
Clearance (CL): | 11.304 | Half-life (T1/2): | 0.082 |
hERG Blockers: | 0.482 | Human Hepatotoxicity (H-HT): | 0.928 |
Drug-inuced Liver Injury (DILI): | 0.832 | AMES Toxicity: | 0.028 |
Rat Oral Acute Toxicity: | 0.812 | Maximum Recommended Daily Dose: | 0.954 |
Skin Sensitization: | 0.157 | Carcinogencity: | 0.076 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.015 |
Respiratory Toxicity: | 0.961 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006060 | ![]() |
0.808 | D0M6VK | ![]() |
0.240 | ||
ENC004543 | ![]() |
0.802 | D09NNH | ![]() |
0.239 | ||
ENC003936 | ![]() |
0.784 | D0V3ZA | ![]() |
0.238 | ||
ENC005127 | ![]() |
0.748 | D04LHJ | ![]() |
0.238 | ||
ENC005128 | ![]() |
0.611 | D0B7YT | ![]() |
0.234 | ||
ENC003937 | ![]() |
0.588 | D0D4IH | ![]() |
0.233 | ||
ENC005759 | ![]() |
0.549 | D0SP3D | ![]() |
0.232 | ||
ENC005758 | ![]() |
0.529 | D05ZJG | ![]() |
0.230 | ||
ENC003955 | ![]() |
0.517 | D0IN7I | ![]() |
0.230 | ||
ENC006133 | ![]() |
0.517 | D0TB8C | ![]() |
0.229 |